Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Innovative Medicine Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Biological Medicine
1.2.3 Chemical Medicine
1.3 Market by Application
1.3.1 Global Innovative Medicine Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Innovative Medicine Market Perspective (2018-2034)
2.2 Innovative Medicine Growth Trends by Region
2.2.1 Global Innovative Medicine Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Innovative Medicine Historic Market Size by Region (2018-2023)
2.2.3 Innovative Medicine Forecasted Market Size by Region (2024-2034)
2.3 Innovative Medicine Market Dynamics
2.3.1 Innovative Medicine Industry Trends
2.3.2 Innovative Medicine Market Drivers
2.3.3 Innovative Medicine Market Challenges
2.3.4 Innovative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Innovative Medicine Players by Revenue
3.1.1 Global Top Innovative Medicine Players by Revenue (2018-2023)
3.1.2 Global Innovative Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Innovative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Innovative Medicine Revenue
3.4 Global Innovative Medicine Market Concentration Ratio
3.4.1 Global Innovative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Innovative Medicine Revenue in 2024
3.5 Innovative Medicine Key Players Head office and Area Served
3.6 Key Players Innovative Medicine Product Solution and Service
3.7 Date of Enter into Innovative Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Innovative Medicine Breakdown Data by Type
4.1 Global Innovative Medicine Historic Market Size by Type (2018-2023)
4.2 Global Innovative Medicine Forecasted Market Size by Type (2024-2034)
5 Innovative Medicine Breakdown Data by Application
5.1 Global Innovative Medicine Historic Market Size by Application (2018-2023)
5.2 Global Innovative Medicine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Innovative Medicine Market Size (2018-2034)
6.2 North America Innovative Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Innovative Medicine Market Size by Country (2018-2023)
6.4 North America Innovative Medicine Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Innovative Medicine Market Size (2018-2034)
7.2 Europe Innovative Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Innovative Medicine Market Size by Country (2018-2023)
7.4 Europe Innovative Medicine Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Innovative Medicine Market Size (2018-2034)
8.2 Asia-Pacific Innovative Medicine Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Innovative Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Innovative Medicine Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Innovative Medicine Market Size (2018-2034)
9.2 Latin America Innovative Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Innovative Medicine Market Size by Country (2018-2023)
9.4 Latin America Innovative Medicine Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Innovative Medicine Market Size (2018-2034)
10.2 Middle East & Africa Innovative Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Innovative Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Innovative Medicine Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Innovative Medicine Introduction
11.1.4 Pfizer Revenue in Innovative Medicine Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Innovative Medicine Introduction
11.2.4 Roche Revenue in Innovative Medicine Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Innovative Medicine Introduction
11.3.4 Sanofi Revenue in Innovative Medicine Business (2018-2023)
11.3.5 Sanofi Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Innovative Medicine Introduction
11.4.4 Johnson & Johnson Revenue in Innovative Medicine Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Innovative Medicine Introduction
11.5.4 Merck & Co. Revenue in Innovative Medicine Business (2018-2023)
11.5.5 Merck & Co. Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Innovative Medicine Introduction
11.6.4 Novartis Revenue in Innovative Medicine Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Innovative Medicine Introduction
11.7.4 AbbVie Revenue in Innovative Medicine Business (2018-2023)
11.7.5 AbbVie Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Innovative Medicine Introduction
11.8.4 Gilead Sciences Revenue in Innovative Medicine Business (2018-2023)
11.8.5 Gilead Sciences Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Detail
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Innovative Medicine Introduction
11.9.4 GlaxoSmithKline Revenue in Innovative Medicine Business (2018-2023)
11.9.5 GlaxoSmithKline Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Innovative Medicine Introduction
11.10.4 Amgen Revenue in Innovative Medicine Business (2018-2023)
11.10.5 Amgen Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Innovative Medicine Introduction
11.11.4 AstraZeneca Revenue in Innovative Medicine Business (2018-2023)
11.11.5 AstraZeneca Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Innovative Medicine Introduction
11.12.4 Bristol-Myers Squibb Revenue in Innovative Medicine Business (2018-2023)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Detail
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Innovative Medicine Introduction
11.13.4 Eli Lilly Revenue in Innovative Medicine Business (2018-2023)
11.13.5 Eli Lilly Recent Development
11.14 Bayer
11.14.1 Bayer Company Detail
11.14.2 Bayer Business Overview
11.14.3 Bayer Innovative Medicine Introduction
11.14.4 Bayer Revenue in Innovative Medicine Business (2018-2023)
11.14.5 Bayer Recent Development
11.15 Novo Nordisk
11.15.1 Novo Nordisk Company Detail
11.15.2 Novo Nordisk Business Overview
11.15.3 Novo Nordisk Innovative Medicine Introduction
11.15.4 Novo Nordisk Revenue in Innovative Medicine Business (2018-2023)
11.15.5 Novo Nordisk Recent Development
11.16 Allergan
11.16.1 Allergan Company Detail
11.16.2 Allergan Business Overview
11.16.3 Allergan Innovative Medicine Introduction
11.16.4 Allergan Revenue in Innovative Medicine Business (2018-2023)
11.16.5 Allergan Recent Development
11.17 Takeda
11.17.1 Takeda Company Detail
11.17.2 Takeda Business Overview
11.17.3 Takeda Innovative Medicine Introduction
11.17.4 Takeda Revenue in Innovative Medicine Business (2018-2023)
11.17.5 Takeda Recent Development
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Detail
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Innovative Medicine Introduction
11.18.4 Boehringer Ingelheim Revenue in Innovative Medicine Business (2018-2023)
11.18.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Innovative Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Biological Medicine
Table 3. Key Players of Chemical Medicine
Table 4. Global Innovative Medicine Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Innovative Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Innovative Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Innovative Medicine Market Share by Region (2018-2023)
Table 8. Global Innovative Medicine Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Innovative Medicine Market Share by Region (2024-2034)
Table 10. Innovative Medicine Market Trends
Table 11. Innovative Medicine Market Drivers
Table 12. Innovative Medicine Market Challenges
Table 13. Innovative Medicine Market Restraints
Table 14. Global Innovative Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Innovative Medicine Market Share by Players (2018-2023)
Table 16. Global Top Innovative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Medicine as of 2024)
Table 17. Ranking of Global Top Innovative Medicine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Innovative Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Innovative Medicine Product Solution and Service
Table 21. Date of Enter into Innovative Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Innovative Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Innovative Medicine Revenue Market Share by Type (2018-2023)
Table 25. Global Innovative Medicine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Innovative Medicine Revenue Market Share by Type (2024-2034)
Table 27. Global Innovative Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Innovative Medicine Revenue Market Share by Application (2018-2023)
Table 29. Global Innovative Medicine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Innovative Medicine Revenue Market Share by Application (2024-2034)
Table 31. North America Innovative Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Innovative Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Innovative Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Innovative Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Innovative Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Innovative Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Innovative Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Innovative Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Innovative Medicine Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Innovative Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Innovative Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Innovative Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Innovative Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Innovative Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Innovative Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Innovative Medicine Product
Table 49. Pfizer Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Innovative Medicine Product
Table 54. Roche Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Innovative Medicine Product
Table 59. Sanofi Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Innovative Medicine Product
Table 64. Johnson & Johnson Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Merck & Co. Company Detail
Table 67. Merck & Co. Business Overview
Table 68. Merck & Co. Innovative Medicine Product
Table 69. Merck & Co. Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 70. Merck & Co. Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Innovative Medicine Product
Table 74. Novartis Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. AbbVie Company Detail
Table 77. AbbVie Business Overview
Table 78. AbbVie Innovative Medicine Product
Table 79. AbbVie Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 80. AbbVie Recent Development
Table 81. Gilead Sciences Company Detail
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Innovative Medicine Product
Table 84. Gilead Sciences Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 85. Gilead Sciences Recent Development
Table 86. GlaxoSmithKline Company Detail
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Innovative Medicine Product
Table 89. GlaxoSmithKline Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Amgen Company Detail
Table 92. Amgen Business Overview
Table 93. Amgen Innovative Medicine Product
Table 94. Amgen Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 95. Amgen Recent Development
Table 96. AstraZeneca Company Detail
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Innovative Medicine Product
Table 99. AstraZeneca Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Bristol-Myers Squibb Company Detail
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Innovative Medicine Product
Table 104. Bristol-Myers Squibb Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Eli Lilly Company Detail
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Innovative Medicine Product
Table 109. Eli Lilly Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Bayer Company Detail
Table 112. Bayer Business Overview
Table 113. Bayer Innovative Medicine Product
Table 114. Bayer Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 115. Bayer Recent Development
Table 116. Novo Nordisk Company Detail
Table 117. Novo Nordisk Business Overview
Table 118. Novo Nordisk Innovative Medicine Product
Table 119. Novo Nordisk Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 120. Novo Nordisk Recent Development
Table 121. Allergan Company Detail
Table 122. Allergan Business Overview
Table 123. Allergan Innovative Medicine Product
Table 124. Allergan Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 125. Allergan Recent Development
Table 126. Takeda Company Detail
Table 127. Takeda Business Overview
Table 128. Takeda Innovative Medicine Product
Table 129. Takeda Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 130. Takeda Recent Development
Table 131. Boehringer Ingelheim Company Detail
Table 132. Boehringer Ingelheim Business Overview
Table 133. Boehringer Ingelheim Innovative Medicine Product
Table 134. Boehringer Ingelheim Revenue in Innovative Medicine Business (2018-2023) & (US$ Million)
Table 135. Boehringer Ingelheim Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Innovative Medicine Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Innovative Medicine Market Share by Type: 2024 VS 2034
Figure 3. Biological Medicine Features
Figure 4. Chemical Medicine Features
Figure 5. Global Innovative Medicine Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 6. Global Innovative Medicine Market Share by Application: 2024 VS 2034
Figure 7. Oncology Case Studies
Figure 8. Neurosciences Case Studies
Figure 9. Immunology Case Studies
Figure 10. Respiratory Case Studies
Figure 11. Others Case Studies
Figure 12. Innovative Medicine Report Years Considered
Figure 13. Global Innovative Medicine Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Innovative Medicine Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Innovative Medicine Market Share by Region: 2024 VS 2034
Figure 16. Global Innovative Medicine Market Share by Players in 2024
Figure 17. Global Top Innovative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Medicine as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Innovative Medicine Revenue in 2024
Figure 19. North America Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Innovative Medicine Market Share by Country (2018-2034)
Figure 21. United States Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Innovative Medicine Market Share by Country (2018-2034)
Figure 25. Germany Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Innovative Medicine Market Share by Region (2018-2034)
Figure 33. China Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Innovative Medicine Market Share by Country (2018-2034)
Figure 41. Mexico Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Innovative Medicine Market Share by Country (2018-2034)
Figure 45. Turkey Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Innovative Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 48. Roche Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 49. Sanofi Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 51. Merck & Co. Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 53. AbbVie Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 54. Gilead Sciences Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 56. Amgen Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 57. AstraZeneca Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 59. Eli Lilly Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 60. Bayer Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 61. Novo Nordisk Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 62. Allergan Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 63. Takeda Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 64. Boehringer Ingelheim Revenue Growth Rate in Innovative Medicine Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed